News and Trends 16 Jun 2023
Novartis acquires Chinook Therapeutics for $3.2B
Novartis has entered into an agreement to acquire Chinook Therapeutics, a Seattle, Washington, based clinical stage biopharmaceutical company with two high-value, late-stage medicines in development for rare, severe chronic kidney…